ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer

Clinical trial NCT03136640 · COMPLETED

Trial details

NCT number: NCT03136640
Sponsor: Modra Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Castration-resistant Prostate Cancer

Start date: 2017-04-26
Primary completion: 2019-09-05
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.